Treatment of patients with tumor/treatment-related hypothalamic obesity in the first two years following surgical treatment or radiotherapy

Treatment of patients with tumor/treatment-related hypothalamic obesity in the first two years following surgical treatment or radiotherapy

Abstract Survivors of sellar/suprasellar tumors involving hypothalamic structures face a risk of impaired quality of life, including tumor- and/or treatment-related hypothalamic obesity (TTR-HO) defined as abnormal weight gain resulting in severe persistent obesity due to physical, tumor- and/or tre...

Full description

Saved in:
Bibliographic Details
Main Authors: Hermann L. Müller, Julian Witte, Bastian Surmann, Manuel Batram, Kylie Braegelmann, Mathias Flume, Julia Beckhaus, Nicolas Touchot, Carsten Friedrich
Format: Article
Language:English
Published: Nature Portfolio 2025-01-01
Series:Scientific Reports
Subjects:
Hypothalamic obesity
Tumor/treatment related HO
Rare sellar/suprasellar tumors
Craniopharyngioma
Endocrinology
Online Access:https://doi.org/10.1038/s41598-025-85262-1
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

https://doi.org/10.1038/s41598-025-85262-1

Similar Items